These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 11681414)
1. Mutation of the p51/p63 gene is associated with blastic crisis in chronic myelogenous leukemia. Yamaguchi H; Inokuchi K; Sakuma Y; Dan K Leukemia; 2001 Nov; 15(11):1729-34. PubMed ID: 11681414 [TBL] [Abstract][Full Text] [Related]
2. Mutational analysis of p51A/TAp63gamma, a p53 homolog, in non-small cell lung cancer and breast cancer. Sunahara M; Shishikura T; Takahashi M; Todo S; Yamamoto N; Kimura H; Kato S; Ishioka C; Ikawa S; Ikawa Y; Nakagawara A Oncogene; 1999 Jun; 18(25):3761-5. PubMed ID: 10391684 [TBL] [Abstract][Full Text] [Related]
3. Effects of p51/p63 missense mutations on transcriptional activities of p53 downstream gene promoters. Kato S; Shimada A; Osada M; Ikawa S; Obinata M; Nakagawara A; Kanamaru R; Ishioka C Cancer Res; 1999 Dec; 59(23):5908-11. PubMed ID: 10606233 [TBL] [Abstract][Full Text] [Related]
4. Frequent alteration of p63 expression in human primary bladder carcinomas. Park BJ; Lee SJ; Kim JI; Lee SJ; Lee CH; Chang SG; Park JH; Chi SG Cancer Res; 2000 Jul; 60(13):3370-4. PubMed ID: 10910040 [TBL] [Abstract][Full Text] [Related]
5. Mutation and transcription analyses of the p63 gene in cervical carcinoma. Nishi H; Isaka K; Sagawa Y; Usuda S; Fujito A; Ito H; Senoo M; Kato H; Takayama M Int J Oncol; 1999 Dec; 15(6):1149-53. PubMed ID: 10568821 [TBL] [Abstract][Full Text] [Related]
6. Expression of p53 and its homologues in primary and recurrent squamous cell carcinomas of the head and neck. Weber A; Bellmann U; Bootz F; Wittekind C; Tannapfel A Int J Cancer; 2002 May; 99(1):22-8. PubMed ID: 11948487 [TBL] [Abstract][Full Text] [Related]
7. Expression of the p53 homologues p63 and p73 in multiple simultaneous gastric cancer. Tannapfel A; Schmelzer S; Benicke M; Klimpfinger M; Kohlhaw K; Mössner J; Engeland K; Wittekind C J Pathol; 2001 Sep; 195(2):163-70. PubMed ID: 11592094 [TBL] [Abstract][Full Text] [Related]
8. p53CP is p51/p63, the third member of the p53 gene family: partial purification and characterization. Tan M; Bian J; Guan K; Sun Y Carcinogenesis; 2001 Feb; 22(2):295-300. PubMed ID: 11181451 [TBL] [Abstract][Full Text] [Related]
9. p53 gene family p51(p63)-encoded, secondary transactivator p51B(TAp63alpha) occurs without forming an immunoprecipitable complex with MDM2, but responds to genotoxic stress by accumulation. Okada Y; Osada M; Kurata S; Sato S; Aisaki K; Kageyama Y; Kihara K; Ikawa Y; Katoh I Exp Cell Res; 2002 Jun; 276(2):194-200. PubMed ID: 12027449 [TBL] [Abstract][Full Text] [Related]
10. Expression profiles of p53, p63, and p73 in benign salivary gland tumors. Weber A; Langhanki L; Schütz A; Gerstner A; Bootz F; Wittekind C; Tannapfel A Virchows Arch; 2002 Nov; 441(5):428-36. PubMed ID: 12447671 [TBL] [Abstract][Full Text] [Related]
11. Mutation analysis of the p51 gene and correlation between p53, p73, and p51 expressions in prostatic carcinoma. Takahashi H; Fukutome K; Watanabe M; Furusato M; Shiraishi T; Ito H; Suzuki H; Ikawa S; Hano H Prostate; 2001 May; 47(2):85-90. PubMed ID: 11340630 [TBL] [Abstract][Full Text] [Related]
12. Analysis of molecular interactions of the p53-family p51(p63) gene products in a yeast two-hybrid system: homotypic and heterotypic interactions and association with p53-regulatory factors. Kojima T; Ikawa Y; Katoh I Biochem Biophys Res Commun; 2001 Mar; 281(5):1170-5. PubMed ID: 11243857 [TBL] [Abstract][Full Text] [Related]
13. Evolutionarily conserved expression pattern and trans-regulating activity of Xenopus p51/p63. Tomimori Y; Katoh I; Kurata S; Okuyama T; Kamiyama R; Ikawa Y Biochem Biophys Res Commun; 2004 Jan; 313(2):230-6. PubMed ID: 14684151 [TBL] [Abstract][Full Text] [Related]
14. TAp63gamma (p51A) and dNp63alpha (p73L), two major isoforms of the p63 gene, exert opposite effects on the vascular endothelial growth factor (VEGF) gene expression. Senoo M; Matsumura Y; Habu S Oncogene; 2002 Apr; 21(16):2455-65. PubMed ID: 11971180 [TBL] [Abstract][Full Text] [Related]
15. Transcriptional dysregulation of the p73L / p63 / p51 / p40 / KET gene in human squamous cell carcinomas: expression of Delta Np73L, a novel dominant-negative isoform, and loss of expression of the potential tumour suppressor p51. Senoo M; Tsuchiya I; Matsumura Y; Mori T; Saito Y; Kato H; Okamoto T; Habu S Br J Cancer; 2001 May; 84(9):1235-41. PubMed ID: 11336476 [TBL] [Abstract][Full Text] [Related]
16. Adenovirus-mediated transfer of the p53 family genes, p73 and p51/p63 induces cell cycle arrest and apoptosis in colorectal cancer cell lines: potential application to gene therapy of colorectal cancer. Sasaki Y; Morimoto I; Ishida S; Yamashita T; Imai K; Tokino T Gene Ther; 2001 Sep; 8(18):1401-8. PubMed ID: 11571580 [TBL] [Abstract][Full Text] [Related]
17. Adenovirus-mediated transfer of p53-related genes induces apoptosis of human cancer cells. Ishida S; Yamashita T; Nakaya U; Tokino T Jpn J Cancer Res; 2000 Feb; 91(2):174-80. PubMed ID: 10761704 [TBL] [Abstract][Full Text] [Related]
18. P53, p15INK4B, p16INK4A and p57KIP2 mutations during the progression of chronic myeloid leukemia. Güran S; Bahçe M; Beyan C; Korkmaz K; Yalçin A Haematologia (Budap); 1998; 29(3):181-93. PubMed ID: 10069444 [TBL] [Abstract][Full Text] [Related]
19. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Yang A; Kaghad M; Wang Y; Gillett E; Fleming MD; Dötsch V; Andrews NC; Caput D; McKeon F Mol Cell; 1998 Sep; 2(3):305-16. PubMed ID: 9774969 [TBL] [Abstract][Full Text] [Related]
20. p51/p63, a novel p53 homologue, potentiates p53 activity and is a human cancer gene therapy candidate. Kunisaki R; Ikawa S; Maeda T; Nakazaki Y; Kurita R; Harata M; Shutoh Y; Bai YS; Soda Y; Tanabe T; Dohi T; Kato R; Ikawa Y; Asano S; Tani K J Gene Med; 2006 Sep; 8(9):1121-30. PubMed ID: 16832836 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]